Delivery Order SPE2DB20D2104-SPE2DB25FMUGR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets, with a ceiling value of $1,810.85. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.09 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.32 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets (UU 21S) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $11,998.92 delivery order to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 60 mg tablets (30-count packaging) on August 7, 2025, with completion expected by August 8, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed price contract type and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,246.44 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets in a 30-count configuration. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Pyridostigmine Bromide 60 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,119.93 and an ultimate completion date of September 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $14,166.32 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets with an ultimate completion date of September 19, 2025. This is a firm fixed-price delivery order under a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 60 mg tablets (30-count packages) on September 5, 2025, with a ceiling value of $2,051.45 and ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,105.04 for Pyridostigmine Extended Release 180 mg tablets in quantities of 30 units on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order represents a non-competitive award issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is for the delivery of Pyridostigmine Bromide 60 mg tablets, with a ceiling value of $1,105.59 and a period of performance through June 27, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMUGRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets (30-count units) with a ceiling value of $1,142.40. The contract utilizes firm fixed price terms and carries an ultimate completion date of July 1, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Pyridostigmine bromide is a cholinesterase inhibitor commonly used in military and veteran healthcare settings, particularly for myasthenia gravis treatment and chemical defense preparedness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/30/25 |